# Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

> **NCT00238407** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 21 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Docetaxel and Cisplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00238407
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2008-02
- **Final completion:** 2010-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238407, "Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00238407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*